Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
https://finance.yahoo.com/amphtml/news/amarin-vascepa-part-c...

This article is talking about Kaiser permanente NorCal doing a study about vascepa as a way to reduce the risk of complications from viral
Respiratory illnesses in older adults with heart disease.

What I glean from it is Amarin riding the cost tails of intense interest in anything COVID related to showcase vascepas cardiovascular benefits. Smart marketing I suppose.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.